US · Healthcare · Health Information Services
EPS came in at -1.12 against a street estimate of -1.05 — a miss of 6.7%.
Analysts rate Aclarion Inc a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.62.
| Fund | Stake |
|---|---|
| Bridgeway Capital Management, LLC | 0.68% |
| CapTrust Financial Advisors | 0.59% |
| Vanguard Fiduciary Trust Co | 0.56% |
| Susquehanna International Group, LLP | 0.53% |
| Geode Capital Management, LLC | 0.42% |
| XTX Topco Ltd | 0.38% |
| Bank of Montreal | 0.35% |
| BMO Capital Markets Corp. | 0.35% |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Aclarion Inc — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-19.